|Articles|October 23, 2007

FDA extends deadline for e-prescribing comments

Dec. 6 is new deadline for public comments regarding electronic distribution of prescribing information for Rx drugs.

Apparently not satisfied with the volume of comments it has received, the FDA has extended the comment period regarding electronic distribution of prescribing information for prescription drug products. The new deadline for comments, as published in the Oct. 22

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Subscribe Now!

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

FDA extends deadline for e-prescribing comments

Newsletter

Related Content

What the Newest Landmark PBM Reform Means for the Pharmacy Industry

New Monthly GLP-1 Data Shows Potential in Obesity Management With Monthly Dosing

FDA Approves Sildenafil as First Oral Film to Treat Men With Erectile Dysfunction

Antimicrobial Pharmacists Optimize Antibiotic Use to Mitigate Resistance

Q&A: How Direct-to-Consumer Pharmacies Could Affect the Pharmacy Landscape

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs (Pharmacy Technician Credit)

Empowering Patients With COPD: The Pharmacist's Role in Personalized Treatment Strategies

Understanding the Pearls and Pitfalls of Nimodipine in Aneurysmal Subarachnoid Hemorrhage: Opportunities to Improve Patient Outcomes

Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Pharmacy Technician Credit)

Implementing Updated RSV Vaccination Recommendations for Older Adults: RSV Case Discussion (Pharmacy Technician Credit)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Pharmacy Technician Credit)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Part 2)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Part 1)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Part 3)

Implementing Updated RSV Vaccination Recommendations for Older Adults: RSV Case Discussion

Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Pharmacy Technician Credit)

Navigating Diabetes: A Guide to Effective Oral Treatments

Exploring HIV Long-Acting Injectable Uptake: How Pharmacists Can Encourage Long-Acting Injectables to Stem the Spread of HIV

Advancing Acute Pain Care: Breakthrough Non-Opioid Therapies and the Pharmacist's Critical Role

Optimizing LDL-C Lowering and Adherence to Hyperlipidemia Guidelines

Hyperlipidemia Overview and the Clinical and Economic Burden

Best Practices for Management of Hyperlipidemia: A Focus on Guidelines and Patient Adherence

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

The Role of the Pharmacist in the Management of Hyperlipidemia

Trending on Drug Topics

Addressing Depression Symptoms Can Significantly Improve Asthma Outcomes

CagriSema Demonstrates Superior Hemoglobin and Weight Loss Results in Type 2 Diabetes

How New Federal Spending Bill Bolsters CMS Oversight, PBM Transparency

Q&A: How Direct-to-Consumer Pharmacies Could Affect the Pharmacy Landscape

Wicked Good Cardiometabolic Chat: Newest Updates to ADA Standards of Care